SCHEMBL196011

SCHEMBL196011

CCCC[CH]C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1416084 0.92
SCHEMBL7146817 0.90 FAAH (0.57)
SCHEMBL11322157 0.90 FAAH (0.57)
SCHEMBL9759038 0.90 FAAH (0.57)
SCHEMBL11316842 0.90 FAAH (0.57)
SCHEMBL16458602 0.90 FAAH (0.57)
SCHEMBL10656809 0.90 FAAH (0.57)
SCHEMBL28178796 0.90 FAAH (0.57)
SCHEMBL288323 0.83
SCHEMBL1289830 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 712 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9187491-B2 Gambogenic acid derivatives, preparation method and application thereof NINTH PEOPLE'S HOSPITAL, SCHOOL MEDICINE SHANGHAI JIAO TONG UNIVERSITY (CN) 2015-11-17 US claimed
EP-2805956-A1 GAMBOGENIC ACID DERIVATIVES, PREPARATION METHOD AND APPLICATION THEREOF Ninth People's Hospital, School Medicine Shanghai Jiao Tong University (CN) 2014-11-26 EP claimed
US-20140309418-A1 Gambogenic Acid Derivatives, Preparation Method and Application Thereof NINTH PEOPLE'S HOSPITAL, SCHOOL MEDICINE SHANGHAI JIAO TONG UNIVERSITY (CN) 2014-10-16 US claimed
EP-2691403-A1 NEW BORANOPHOSPHATE ANALOGUES OF CYCLIC NUCLEOTIDES BIOLOG Life Science Institute Forschungslabor Und Biochemica-Vertrieb GmbH (DE) 2014-02-05 EP claimed
WO-2012130829-A1 NEW BORANOPHOSPHATE ANALOGUES OF CYCLIC NUCLEOTIDES BIOLOG LIFE SCIENCE INSTITUTE FORSCHUNGSLABOR UND BIOCHEMICA-VERTRIEB GMBH (DE) 2012-10-04 WO claimed
US-7714025-B2 Modified chalcone compounds as antimitotic agents ARIZONA BIOMEDICAL RESEARCH COMMISSION (US) 2010-05-11 US claimed
US-20070265317-A1 MODIFIED CHALCONE COMPOUNDS AS ANTIMITOTIC AGENTS ARIZONA BIOMEDICAL RESEARCH COMMISSION (US) 2007-11-15 US claimed
US-20070238893-A1 Asymmetric hydrogenation of acyl enamides TEVA PHARMACEUTICAL INDUSTRIES LTD (IL) 2007-10-11 US claimed
WO-2007056403-A2 ASYMMETRIC HYDROGENATION OF ACYL ENAMIDES TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2007-05-18 WO claimed
CN-1747749-A Diagnostic imaging agents with mmp inhibitory activity GE HEALTHCARE LTD (GB) 2006-03-15 CN claimed
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US claimed
WO-2005037797-A1 SUBSTITUTED PYRAZOLE UREA COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2005-04-28 WO claimed
EP-0874846-B1 PURINE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION NOVARTIS AG (CH) 2003-04-02 EP claimed
EP-0874846-A1 PURINE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION Novartis AG (CH) 1998-11-04 EP claimed
WO-1997016452-A1 PURINE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION NOVARTIS AG (CH) 1997-05-09 WO claimed
EP-4373493-A1 BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK WITH ENHANCED IMID ACTIVITY Nurix Therapeutics, Inc. (US) 2024-05-29 EP disclosed
EP-4370123-A1 BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK WITH DIMINISHED IMID ACTIVITY Nurix Therapeutics, Inc. (US) 2024-05-22 EP disclosed
EP-0040408-A1 Beta-lactam compounds and process for production thereof SANRAKU-OCEAN CO., LTD. (JP) 1981-11-25 EP disclosed
US-4284631-A 7-Substituted cephem compounds and pharmaceutical antibacterial compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-08-18 US disclosed
EP-0007633-A2 Cephem compounds, processes for their preparation and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1980-02-06 EP disclosed